These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36213826)

  • 21. Prognostic effect of a novel long noncoding RNA signature and comparison with clinical staging systems for patients with hepatitis B virus-related hepatocellular carcinoma after hepatectomy.
    Wu H; Liu TT; Feng YM; Xie XY; Su XN; Qi JN; Zhu Q; Qin CY
    J Dig Dis; 2020 Nov; 21(11):650-663. PubMed ID: 32959529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of diagnostic long non‑coding RNA biomarkers in patients with hepatocellular carcinoma.
    Li G; Shi H; Wang X; Wang B; Qu Q; Geng H; Sun H
    Mol Med Rep; 2019 Aug; 20(2):1121-1130. PubMed ID: 31173205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic biomarkers and potential drug targets for coronary artery disease as revealed by systematic analysis of lncRNA characteristics.
    Chen Z; Zhou D; Zhang X; Wu Q; Wu G
    Ann Transl Med; 2021 Aug; 9(15):1243. PubMed ID: 34532380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification Of Novel lncRNAs For Detection Of HBV-Associated Hepatocellular Carcinoma.
    Li Y; Chen X; Huang H; Li G; Liao L; Yuan T; Deng S
    Onco Targets Ther; 2019; 12():10199-10211. PubMed ID: 31819509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
    Yang X; Mei M; Yang J; Guo J; Du F; Liu S
    Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA-based signature for predicting prognosis of hepatocellular carcinoma.
    Cao J; Wu L; Lei X; Shi K; Shi L; Shi Y
    Bioengineered; 2021 Dec; 12(1):673-681. PubMed ID: 33622186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Construction and Comprehensive Analyses of a Competing Endogenous RNA Network in Tumor-Node-Metastasis Stage I Hepatocellular Carcinoma.
    Gu X; Li H; Sha L; Zhao W
    Biomed Res Int; 2020; 2020():5831064. PubMed ID: 32104698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma.
    Liu J; Li W; Zhang J; Ma Z; Wu X; Tang L
    PeerJ; 2019; 7():e8021. PubMed ID: 31695969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
    Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
    Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a Five-Autophagy-Related-lncRNA Signature as a Novel Prognostic Biomarker for Hepatocellular Carcinoma.
    Deng X; Bi Q; Chen S; Chen X; Li S; Zhong Z; Guo W; Li X; Deng Y; Yang Y
    Front Mol Biosci; 2020; 7():611626. PubMed ID: 33505990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
    Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
    Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma.
    Zhang X; Yu J; Hu J; Tan F; Zhou J; Yang X; Xie Z; Tang H; Dong S; Lei X
    Comb Chem High Throughput Screen; 2021; 24(5):656-667. PubMed ID: 32928078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
    Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
    Front Oncol; 2021; 11():738477. PubMed ID: 34568075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of four prognostic LncRNAs for survival prediction of patients with hepatocellular carcinoma.
    Wang Z; Wu Q; Feng S; Zhao Y; Tao C
    PeerJ; 2017; 5():e3575. PubMed ID: 28729955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a Nine Immune-Related lncRNA Signature as a Novel Diagnostic Biomarker for Hepatocellular Carcinoma.
    Yuan M; Wang Y; Sun Q; Liu S; Xian S; Dai F; Zhang L; Fan Y; Wang F; Yang D; Zheng Y; Deng Z; Tan W; Liu Y; Cheng Y
    Biomed Res Int; 2021; 2021():9798231. PubMed ID: 33506049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.